Biotech Values

[DewDiligence]

Teva is indeed entering the Lipitor market with Ranbaxy,
but don’t even think of asking about the financial terms.

http://finance.yahoo.com/news/Teva-Announces-Agreement-bw-770819240.html?x=0

›Teva Announces Agreement with Ranbaxy Regarding Generic Lipitor

30-Nov-2011 11:00pm ET

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that pursuant to an agreement between its subsidiary, Teva Pharmaceuticals USA, Inc. and Ranbaxy Laboratories Limited ("Ranbaxy"), a portion of the profits from Ranbaxy’s sales of Atorvastatin Calcium Tablets during Ranbaxy’s 180-day first-to-file exclusivity period, will be paid to Teva. Terms of the agreement will not be disclosed.‹